Current guidelines for vesicoureteral reflux in Australian children
Vesicoureteral reflux (VUR) affects approximately 1–2% of Australian children and remains a leading cause of paediatric urinary tract infections (UTIs) and acquired renal scarring. Paediatric urologists at major centres such as the Royal Children's Hospital in Melbourne and Sydney Children's Hospital at Randwick routinely encounter families navigating a confusing landscape of imaging studies, prophylactic antibiotics, and potential surgical correction. Local consensus reflects a clear shift away from reflexive surgical management toward more individualised, risk-stratified care.
Recent international guidelines, synthesised through bodies such as the American Urological Association and the European Association of Urology, have been carefully adapted for Australian practice by the Urological Society of Australia and New Zealand. These recommendations emphasise the centrality of bladder and bowel dysfunction in disease behaviour, the rational use of continuous low-dose prophylaxis, and the growing role of endoscopic injection therapy. The following sections summarise the evidence underpinning current practice and highlight practical points relevant to clinicians across metropolitan and rural settings.
Pathophysiology and clinical presentation in children
VUR describes the retrograde flow of urine from the bladder into the ureter and renal collecting system, primarily due to incompetence of the vesicoureteral junction. The condition is graded I through V using the International Reflux Study classification, with higher grades associated with greater risk of pyelonephritis and renal scarring. Most cases in Australian children are detected after investigation of a febrile UTI, typically in infants and toddlers whose presentation may include irritability, poor feeding, or vomiting rather than the classic flank pain seen in adults.
Genetic predisposition is evident in some families, and VUR is more common in children of Caucasian background, although it occurs across all populations including Aboriginal and Torres Strait Islander children, in whom late presentation and recurrent infections can pose particular challenges. Recognising the underlying mechanisms helps clinicians tailor intervention — for example, distinguishing primary anatomical reflux from secondary reflux driven by high bladder pressures in a child with dysfunctional voiding.
Diagnostic imaging pathways
Atypical or recurrent febrile UTIs in children under five usually prompt a renal tract ultrasound as the first-line investigation. If ultrasound shows hydronephrosis, scarring, or duplicated systems, the next step is a voiding cystourethrogram (VCUG) or, where available, a contrast-enhanced voiding urosonography. Nuclear studies using dimercaptosuccinic acid (DMSA) provide the most sensitive assessment of renal cortical defects and are typically performed 4–6 months after an acute infection to identify established scarring.
The trend across Australian tertiary paediatric centres is to limit radiation exposure by reserving VCUG for cases where the result will directly influence management. A review of recent findings highlighted how risk-based imaging algorithms can reduce unnecessary catheterisation while preserving diagnostic yield, particularly when families live far from specialist centres and repeat visits are difficult to coordinate.
Continuous low-dose antibiotic prophylaxis
For decades, daily trimethoprim, nitrofurantoin, or cephalexin has been the cornerstone of VUR management in young children. Contemporary evidence, including the RIVUR and PRIVENT trials, suggests prophylaxis reduces recurrence of febrile UTI but does not consistently prevent new renal scarring, particularly in low-grade reflux. Australian prescribers, working within the Pharmaceutical Benefits Scheme, generally reserve prophylaxis for children under two years with higher-grade (III–V) VUR or recurrent infections despite conservative measures.
Shared decision-making is essential. Clinicians at the Queensland Children's Hospital commonly use decision aids that outline the modest absolute risk reduction alongside considerations such as antimicrobial resistance and family preference. Parents in suburban Brisbane or regional Townsville may have very different views about long-term medication, and culturally appropriate counselling remains a key part of the consent process.
Surgical and endoscopic interventions
Ureteral reimplantation, performed as an open or minimally invasive procedure, remains the definitive treatment for persistent high-grade VUR. Open Cohen or Politano–Leadbetter techniques achieve resolution rates above 95% but involve a hospital stay of several days and a catheter period that many Australian families find disruptive. Laparoscopic and robot-assisted approaches, available in selected tertiary units, may shorten recovery but require specific expertise.
Endoscopic injection of a bulking agent such as Deflux has become the first-line surgical option for many Australian children with grades II–IV reflux. The procedure is typically performed as a day case, with success rates of 70–85% per injection. When families are exploring these options, browsing recent journal issues can provide valuable context on emerging surgical techniques and long-term outcome data.
Bladder and bowel dysfunction management
Lower urinary tract dysfunction is now recognised as one of the most important modifiable factors influencing VUR resolution and breakthrough infection risk. Constipation, in particular, is highly prevalent in Australian preschoolers and contributes to bladder overdistension and elevated voiding pressures. Structured urotherapy programmes, including timed voiding, double voiding, and adequate fluid intake, are first-line interventions that often obviate the need for surgery.
Biofeedback and pelvic floor retraining can be useful in older children with persistent dysfunctional voiding. Where overactive bladder symptoms dominate, clinicians increasingly consider targeted pharmacotherapy — a topic explored in detail in a recent piece on pharmacotherapies for overactive bladder that complements this discussion nicely.
Follow-up, renal scarring, and long-term outcomes
The natural history of VUR is resolution in approximately 80% of low-grade cases over five to ten years, but higher grades resolve less reliably. Children with established renal scarring require lifelong blood pressure monitoring, with annual checks recommended through adolescence and into early adulthood. Pregnancy planning is an important conversation for adolescent females, as reflux nephropathy increases the risk of hypertension and pre-eclampsia.
Transition services, exemplified by joint paediatric–adult clinics in Perth and Adelaide, help young people move smoothly from paediatric to adult urology care. These clinics also play a key role in documenting prior imaging and ensuring that women with a history of renal scarring receive appropriate counselling before conception.
| Strategy | Best suited for | Key advantages | Notable limitations |
|---|---|---|---|
| Watchful waiting with urotherapy | Grades I–II, no breakthrough UTIs | Avoids medication; respects natural resolution | Requires reliable follow-up |
| Continuous antibiotic prophylaxis | Children under 2 years, grades III–V | Reduces febrile UTI recurrence | Resistance concerns; modest effect on scarring |
| Endoscopic injection | Grades II–IV, failed prophylaxis | Day-case procedure; minimally invasive | Lower success than reimplantation |
| Open or laparoscopic reimplantation | Persistent high-grade VUR | Highest long-term success | Surgical morbidity; longer recovery |
Practical recommendations for clinicians and families
Modern management of paediatric VUR depends on careful phenotyping rather than reflexive intervention. The recommendations below reflect current Australian practice and align with international consensus.
- Confirm the diagnosis with the least invasive imaging modality appropriate to the clinical question.
- Treat constipation and dysfunctional voiding before considering escalation of VUR therapy.
- Reserve continuous antibiotic prophylaxis for children at highest risk of recurrent febrile infection.
- Discuss endoscopic injection as a minimally invasive option for grades II–IV reflux with families seeking active intervention.
- Offer ureteral reimplantation when lower grades of intervention have failed or anatomy dictates open correction.
- Monitor blood pressure and renal function annually in any child with documented renal scarring.
- Plan structured transition from paediatric to adult services for adolescents with persistent or surgically managed VUR.
For clinicians seeking deeper coverage of evolving practice, the journal's archive provides a rich source of original research and review articles across the spectrum of paediatric urology. Readers are encouraged to consult the most recent issues for updates on long-term outcome studies, novel surgical techniques, and the expanding evidence base for non-antibiotic management of recurrent UTIs in children.